Oral Session 2-7C PTCL/NK lymphoma: Treatment (2)

[OS2-7C-5] Successful application of RHOA p.G17V status for diagnosis and disease monitoring in a case of AITL

Mai Mizusawa¹, Miho Ogawa², Kazuaki Yokoyama¹, Toyotaka Kawamata¹, Shohei Andoh¹, Kanya Kondoh¹, Tomomi Takei², Sousuke Nakamura², Mika Ito², Nozomi Yusa³, Rika Kasajima⁴, Eigo Shimizu⁵, Junya Makiyama¹, Hiroshi Yasui¹, Rui Yamaguchi⁵, Seiya Imoto⁴, Satoru Miyano^4,5, Yasunori Ota⁶, Noritada Yoshikawa⁷, Hirotoshi Tanaka⁷, Yoichi Imai¹, Arinobu Tojo^1,2 (1.Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo, 2.Division of Molecular Therapy, IMSUT, The University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, The University of Tokyo, 4.Health Intelligence Center, IMSUT, The University of Tokyo, 5.Human Genome Center, IMSUT, The University of Tokyo, 6.Pathology and Laboratory Medicine, IMSUT Hospital, The University of Tokyo, 7.Department of Rheumatology, IMSUT Hospital, The University of Tokyo)